Want to join the conversation?
$BAX said the company experienced low teens growth globally in its acute business in 4Q15, driven by underlying market growth and an increased adoption of continuous renal replacement therapy as a treatment option for acute kidney injuries. Renal business growth was offset by lower sales in in-center chronic human dialysis business.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?